Join us online on 1 October at 10:30 for a deep dive into four IHI projects that are revolutionising the fight against blood cancers.

Blood cancers – including leukaemia, lymphoma, and myeloma – affect hundreds of thousands of people across Europe. Many blood cancers are rare and healthcare practices vary across the EU, meaning that a lack of data has traditionally been a challenge. But new approaches to data can make a difference. CAR-T cell therapy has the potential to be a game-changer in blood cancer treatment, but it is not without its challenges, including serious side effects and long manufacturing time lags.

What you will learn:

• How the HARMONY projects have developed a data lake of over 120,000 patient records and more than 100 harmonised databases that is revolutionising real-world data use in haematology
• How the T2Evolve project is investigating how to accelerate the use of CAR-T cell therapies for blood cancers
• How the EASYGEN project is improving CAR-T cell manufacturing which could slash treatment times and costs — making personalised care faster and more accessible

Register here.